Hybrid Event
-
SciLifeLab Metabolomics platform – Metabolomics for the masses
Hybrid Event
SciLifeLab Metabolomics platform – Metabolomics for the masses
Otto Savolainen, SciLifeLab Metabolomics platform
Events and courses
Bringing life science professionals together and furthering skills in the scientific community are in SciLifeLab’s DNA. Our many events and courses, which span a wide range of topics, present opportunities to develop your know-how and share your own experiences and network – sparking new ideas, as well as new collaborations.
Contact
events@scilifelab.se
education@scilifelab.uu.se
If you are part of the SciLifeLab community, you can submit an event to this calendar.
Loading view.
Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
0 events,
1 event,
Hybrid Event
-
Data-driven hallmarks of acute myeloid leukemia: biological, prognostic and therapeutic implications
Hybrid Event
Data-driven hallmarks of acute myeloid leukemia: biological, prognostic and therapeutic implications
Tom Erkers, Assistant professor
Department of Oncology-Pathology, Karolinska Institutet
1 event,
-
[Clinical Talks] A co-creation engine for the next Generation Life Science ventures
[Clinical Talks] A co-creation engine for the next Generation Life Science ventures
Bobby Kaura, Seed Investment, Global Entrepreneurial & Ecosystem Development @ Illumina For Startups
0 events,
0 events,
0 events,
1 event,
Virtual Event
-
TissUUmaps 3: Interactive visualization and quality assessment of large-scale spatial omics
Virtual Event
TissUUmaps 3: Interactive visualization and quality assessment of large-scale spatial omics
We present TissUUmaps, browser-based tool for GPU-accelerated visualization and interactive exploration of tens of millions of datapoints overlaying tissue samples. Users can visualize markers and regions, explore spatial statistics and quantitative analyses of tissue morphology, and assess the quality of decoding in situ transcriptomics data. TissUUmaps provides instant multi-resolution image viewing, can be customized, shared, […]
0 events,
0 events,
1 event,
Virtual Event
-
Ultrasensitive-and-digital sequencing and infrastructure activities within Genomic Medicine Sweden
Virtual Event
Ultrasensitive-and-digital sequencing and infrastructure activities within Genomic Medicine Sweden
During this seminar, Prof. Anders Ståhlberg, Professor in Clinical Genomics at University of Gothenburg, will showcase the applications of ultrasensitive and digital sequencing. Per Sikora, Co-Chair of the Informatics and and Infrastructure at Genomic Medicine Sweden (GMS) as well as part of the GMS management group, will give us an update of the GMS working […]
0 events,
0 events,
0 events,
2 events,
-
FAIRPoints-FAIRPoints ‘Ask me Anything’ (AMA)
FAIRPoints-FAIRPoints ‘Ask me Anything’ (AMA)
FAIRPoints is an event series bringing together people across the research ecosystem to discuss, highlight, and share pragmatic solutions to making FAIR a reality
-
MAX IV new users: introduction and updates – Alexandr Talyzin
MAX IV new users: introduction and updates – Alexandr Talyzin
In the frame of the “SciLifeLab Site Umeå / KBC Infrastructure Seminar Series”, the seminars will be organised every second Tuesday during spring 2023. The seminars will be held in a hybrid format IRL in Glasburen, KBC, and online via Zoom. Take the chance to get information on facilities, possibilities and services that infrastructure, both […]
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
-
Open Hearing: Gothenburg Phenomics – Proof of Concept Project Invitation
Open Hearing: Gothenburg Phenomics – Proof of Concept Project Invitation
The aim is to establish proof-of-concept for life science research with expressed (pre-)clinical relevance. This will be achieved by forming a closed loop from biomedical research question (initiated by pre-clinical researchers) to returning actionable biological results, in terms of mechanisms and potential biomarkers and targets. In this open hearing we would like to identify preclinical […]